Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis

Published:2022-01-26 Issue:3 Volume:16 Page:234-243
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:Clinical Respiratory J

Author:

Jiang Dingyuan¹,Xiao Huijuan¹,Dong Run²³,Geng Jing¹,Xie Bingbing¹,Ren Yanhong¹,Dai Huaping¹²^ORCID

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China‐Japan Friendship Hospital National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine Beijing China

2. Department of Respiratory Medicine Capital Medical University Beijing China

3. Department of Respiratory Medicine Zhengzhou Central Hospital Zhengzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/crj.13475

Reference30 articles.

1. KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung Disease

2. Proteomic approaches for studying human parenchymal lung diseases

3. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line;Kohlgraf KG;Cancer Res,2003

4. MUC1: a multifaceted oncoprotein with a key role in cancer progression

5. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum YKL-40 and Serum Krebs von den Lungen-6 as Potential Predictive Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease;Immunological Investigations;2024-06-20

2. Ciplukan (Physalis angulata Linn) Bioactivity against Bleomycin-Induced Pulmonary Fibrosis in Mice by reducing Subpleural Fibrosis, KL-6 Level and Anti-Inflammatory properties;Research Journal of Pharmacy and Technology;2024-04-22

3. Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease;BMC Pulmonary Medicine;2024-03-15

4. Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis;Biomedicines;2024-01-24

5. Expression and significance of serum KL-6 in patients with acute respiratory distress syndrome;Journal of Thoracic Disease;2023-12